Bronnen:
- Raltegravir Noninferior as Second-Line ART in Low-Resource Settings. www.medscape.com. May 12, 2016,La Rosa AM, Harrison LJ, Taiwo B, et al. Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study. Lancet HIV. 2016;3:e247-58.